Patent ID: 11944669
Assignee: THERIVA BIOLOGICS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A

Claim 6:
7. A formulation comprising a beta-lactamase wherein the formulation comprises at least one pellet with each pellet comprising:
about 2.3% by weight beta-lactamase, the beta-lactamase comprising an amino acid sequence having at least 95% identity with the amino acid sequence selected from SEQ ID NO: 1 and SEQ ID NO: 5;
about 0.3% hydroxypropylmethylcellulose acetate succinate (HPMCAS);
about 10.0% ethylcellulose dispersion;
about 0.1% sodium stearyl fumarate;
about 0.1% buffer; and
about 87.5% water.